Enobia Pharma Receives FDA Orphan Drug Designation For Hypophosphatasia Product Candidate ENB-0040

Enobia Pharma, an emerging biotech company focused on developing novel therapeutics for serious bone disorders, announced that it has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for ENB-0040, its enzyme replacement therapy (ERT) for hypophosphatasia, a rare, life-threatening genetic bone disease. In August 2008, Enobia dosed the first patient in a Phase I clinical trial of ENB-0040.

More: continued here

Comments are closed.



My RX Pharmacy - Buy Online: My RX pharmacy
Online RX Pharmacy - Buy Drugs: Online Rx pharmacy
Online RX Store - Buy Drugs: Store for Rx products
Pills Store Online - Buy Drugs: Pills sotre online
Pills 2 Me - Order RX Pills for You: Just select the medicines you need, fill in our medical questionnaire, and submit your order.
Rx pharma online - : Rx pharma online
Soma Drugs - Soma Pills: Soma is a muscle relaxant used to relieve the pain and stiffness of muscle.
Ultracet PIlls - Ultracet PIlls: Get Ultracet PIlls
Drug any time - : Drug any time
Medical rx pill - : Medical rx pill
Prescript Medicine - : Prescript Medicine
Latest News...